Article
Transcriptome Analysis of Cardiac Hypertrophic Growth in MYBPC3-Null Mice Suggests Early Responders in Hypertrophic Remodeling
25 Oct 2018
Abstract excerpt
Rationale– With a prevalence of 1 in 200 individuals, hypertrophic cardiomyopathy (HCM) is thought to be the most common genetic cardiac disease, with potential outcomes that include severe hypertrophy, heart failure, and sudden cardiac death. Though much research has furthered our understanding of how HCM-causing mutations in genes such as cardiac myosin binding protein C (MYBPC3) impair contractile function, it...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
